
Joshua B. Silverman
PartnerPartner Joshua B. Silverman heads Pomerantz’s Chicago office, where he oversees all the litigation as well as recruiting and training programs. Throughout his nearly two-decade tenure as a partner, Josh has spearheaded numerous high-profile securities class actions and secured historic court precedents.
Josh has achieved substantial securities litigation settlements on behalf of defrauded investors, including $97 million in Perrigo; $80 million in Grab Holdings, which is the second-largest settlement ever in a SPAC-related securities litigation; $45 million in Groupon, one of the highest percentage recoveries in the Seventh Circuit; $29 million in Proterra; over $22 million in MannKind; $18 million in AVEO Pharmaceuticals, which was more than four times the SEC’s fair fund recovery in related litigation; and $17.75 million in Ginkgo Bioworks, another SPAC-related securities litigation.
Josh’s work has established important precedents advancing securities litigation for investors worldwide. For example, MannKind established that investors may support complaints with expert information, and Countrywide recognized that investors may show Section 11 damages for asset-backed securities even if there has been no interruption in payment or threat of default. NantKwest was the first Section 11 case in the nation to recognize statistical proof of traceability.
Alongside Managing Partner Jeremy Lieberman, Josh secured a significant win for investors in a securities fraud class action against Perrigo Co. plc. Judge Arleo of the United States District Court for the District of New Jersey certified investor classes that had purchased Perrigo securities on both the New York Stock Exchange and the Tel Aviv Stock Exchange. This is the first time since Morrison that a U.S. court has independently analyzed the market of a security traded on a non-U.S. exchange and found that it met the standards of market efficiency necessary to allow for class certification.
Josh also played a pivotal role in the firm’s representation of investors before the United States Supreme Court in StoneRidge.
Beyond prosecuting cases, Josh frequently speaks at investor conferences and legal education programs.
Before his tenure at Pomerantz, he practiced at a defense firm in Chicago, where he represented a major independent futures commission merchant in commodities fraud and civil RICO cases. He also spent two years as a securities trader and continues to actively trade stocks, futures, and options for his own account.
Show MoreNotable Cases
Pomerantz secured final court approval of a $97 million settlement for investors in pharmaceutical company Perrigo Co. plc in September 2024, after nearly...
Read MoreOn May 15, 2025, Pomerantz secured final court approval of an $80 million settlement that the firm negotiated for investors in Grab Holdings...
Read MorePomerantz Finalizes Settlement on Behalf of Ginkgo Bioworks Investors On December 13, 2024, the United States District Court for the Northern District of...
Read MorePublications
- “Record-Setting Settlements in Two SPAC-Related Securities Suits,” The D&O Diary, January 14, 2025
- “$7.5 Million Settlement for Faraday Investors,” The Pomerantz Monitor, Vol 21 Issue 6, November/December 2024
- “Joshua Silverman on Finding Post-Morrison Protections for Investors,” Lawdragon, August 26, 2024
- “The Future of Section 10(b) Claims Premised on Violations of Item 303 Looks Uncertain,” The Pomerantz Monitor, Vol 21 Issue 1, January/February 2024
- “Lawyer Limelight: Joshua Silverman,” Lawdragon, August 19, 2021
Credentials
- University of Michigan Law School
-
- Juris Doctor
- University of Michigan
- Bachelors of Science
- Phi Beta Kappa honors
- Bachelors of Science
- Illinois
- United States District Court for the Northern District of Illinois
- United States Courts of Appeals for the First, Second, Third, Seventh, Eighth, and Ninth Circuits
- United States Supreme Court
Accolades
Lawdragon 500 Leading Plaintiff Financial Lawyers (2026)